Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Parker · SciRah

Researcher profile · Semantic Scholar

S. Parker

Share profile

S. Parker — researcher profile on SciRah

h-index: 3
Works: 20
Citations: 174

Most-cited papers

Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology
N. Kuderer, K. Burton, S. Blau, Andrea L. Rose +3 more
2017JAMA Oncology149 citations Open access
Semantic Scholar
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer
P. Chalasani, Kiah J. Farr, V. Wu, I. Jenkins +5 more
2021Breast Cancer Research and Treatment5 citations Open access
Semantic Scholar
Study of the Veterans Affairs Health Care System highlights the impact of COVID-19 on cancer diagnoses in the USA
S. Parker
2021The Lancet Oncology3 citations Open access
Semantic Scholar
Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer
N. Kuderer, K. Burton, S. Blau, F. Senecal +7 more
2017JCO Precision Oncology3 citations Open access
Semantic Scholar
Methylation classifier array and classification of solitary fibrous tumors.
Zachary L. Chelsky, F. Obeidin, B. Alexiev, Lucas Santana-Santos +6 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer
K. Burton, Elisabeth M. Mahen, E. Konnick, S. Blau +21 more
2022JCO Precision Oncology2 citations Open access
Semantic Scholar
Vaccination targeting insulin-like growth factor binding protein-2 (IGFBP-2) in advanced ovarian cancer: Safety and immunogenicity.
John Ben Liao, D. Cecil, Y. Dang, K. Baker +11 more
20162 citations
Semantic Scholar
Abstract OT3-1-02: Phase II randomized study of combination immunotherapy with or without Polysaccharide Krestin (PSK®) concurrently with a HER2 ICD peptide-based vaccine and trastuzumab in patients with stage IV breast cancer
J. Childs, D. Higgins, S. Parker, J. Reichow +4 more
20122 citations
Semantic Scholar
P1-13-04: Phase II Study of Topical Imiquimod and Abraxane for Treatment of Breast Cancer Cutaneous Metastases.
L. G. Salazar, Hai-Ling Lu, H. Gray, D. Higgins +5 more
20112 citations
Semantic Scholar
Cis-Compound Mutations are Prevalent in Triple Negative Breast Cancer and Can Drive Tumor Progression
Naozumi Hiranuma, Jie Liu, ChaoZhong Song, J. Goldsmith +26 more
2016bioRxiv1 citations Open access
Semantic Scholar
OT1-02-10: Phase I-II Study of HER2 Vaccination with Poly(I) • Poly(C12U) (Ampligen®) as an Adjuvant in Optimally Treated Breast Cancer Patients.
D. Higgins, J. Childs, S. Parker, K. Guthrie +2 more
20111 citations
Semantic Scholar
OT3-01-19: Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases.
D. Higgins, J. Childs, S. Parker, M. Disis +1 more
20111 citations
Semantic Scholar
Abstract PS11-13: Multidimensional molecular profiling of repeated metastatic TNBC biopsies in the intensive trial of omics safely guides treatment decisions
K. Burton, E. Konnick, S. Blau, M. Dorschner +14 more
20210 citations
Semantic Scholar
11 Oncologic outcomes and role of adjuvant therapy in endometrial cancer patients with low volume metastasis in the sentinel lymph nodes: an international multi-institutional study
Khaled Ghoniem, G. Dinoi, A. Larish, X. Zhou +33 more
20200 citations Open access
Semantic Scholar
Abstract NTOC-097: VACCINATION TARGETING INSULIN–LIKE GROWTH FACTOR BINDING PROTEIN–2 (IGFBP–2) IN ADVANCED OVARIAN CANCER: SAFETY, IMMUNOGENICITY, AND SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) COMPARISON
J. Liao, D. Cecil, Y. Dang, K. Baker +11 more
20170 citations
Semantic Scholar
PTH-004 Is emr for large colonic polyps clinically and histologically safe?
S. Dixon, S. Parker, P. O'Loughlin
20150 citations
Semantic Scholar
Lunchtime Posters
C. Simillis, D. Baird, I. Panagiotopoulou, N. Pawa +24 more
20150 citations
Semantic Scholar
A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: Preliminary safety and immunogenicity
J. Liao, D. Cecil, J. Reichow, S. Parker +6 more
20140 citations
Semantic Scholar
Abstract P2-15-02: The efficacy of recruitment and retention strategies for research subjects in an early phase investigator-initiated breast cancer trial.
J. Reichow, D. Higgins, S. Parker, J. Childs +2 more
20120 citations
Semantic Scholar
OT2-05-05: Phase I/II Study of Adoptive T Cell Therapy Following In Vivo Priming with a HER2 Peptide-Based Vaccine in Patients with Stage IV Breast Cancer.
S. Parker, D. Higgins, J. Childs, Y. Dang +4 more
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Higgins×9
Invite
D. Higgins — researcher profile on SciRah
J. Childs×9
Invite
J. Childs — researcher profile on SciRah
L. G. Salazar×9
Invite
L. G. Salazar — researcher profile on SciRah
M. Disis×9
Invite
M. Disis — researcher profile on SciRah

×5

Invite

K. Burton — researcher profile on SciRah

Invite

S. Blau — researcher profile on SciRah

Invite

V. Gadi — researcher profile on SciRah

Invite

J. Reichow — researcher profile on SciRah

Invite

F. Senecal — researcher profile on SciRah

Elisabeth M. Mahen×4

Invite

Elisabeth M. Mahen — researcher profile on SciRah

Invite

A. Coveler — researcher profile on SciRah

Invite

C. Blau — researcher profile on SciRah